美联邦政策调整前后阿片类药物治疗项目纳洛酮剂量调整对美沙酮涉及的过量死亡的影响
Methadone-Involved Overdose Deaths in the US Before and After Federal Policy Changes Expanding Take-Home Methadone Doses From Opioid Treatment Programs.
机构信息
National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia.
National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland.
出版信息
JAMA Psychiatry. 2022 Sep 1;79(9):932-934. doi: 10.1001/jamapsychiatry.2022.1776.
Abstract
This observational study assesses whether methadone-involved overdose deaths decreased when opioid treatment programs take-home policies changed during the COVID-19 pandemic.
摘要
本观察性研究评估了在 COVID-19 大流行期间，阿片类药物治疗计划改变了美沙酮相关药物过量死亡是否减少。
相似文献
1
Methadone-Involved Overdose Deaths in the US Before and After Federal Policy Changes Expanding Take-Home Methadone Doses From Opioid Treatment Programs.美联邦政策调整前后阿片类药物治疗项目纳洛酮剂量调整对美沙酮涉及的过量死亡的影响
JAMA Psychiatry. 2022 Sep 1;79(9):932-934. doi: 10.1001/jamapsychiatry.2022.1776.
2
Medicines for Patients After an Opioid Overdose.阿片类药物过量后给患者使用的药物。
Ann Intern Med. 2018 Aug 7;169(3). doi: 10.7326/P18-0009. Epub 2018 Jun 19.
3
History of Methadone and Buprenorphine Opioid Agonist Therapy Among People Who Died of an Accidental Opioid-Involved Overdose: Rhode Island, January 1, 2018-June 30, 2020.美沙酮和丁丙诺啡阿片激动剂治疗史与死于意外阿片类药物过量的人群：罗得岛，2018 年 1 月 1 日-2020 年 6 月 30 日。
Am J Public Health. 2021 Sep;111(9):1600-1603. doi: 10.2105/AJPH.2021.306395. Epub 2021 Aug 19.
4
Methadone-involved overdose deaths in the United States before and during the COVID-19 pandemic.美国 COVID-19 大流行前后涉及美沙酮的药物过量死亡情况。
Drug Alcohol Depend. 2023 Jan 1;242:109703. doi: 10.1016/j.drugalcdep.2022.109703. Epub 2022 Nov 19.
5
Prevention of Opioid Overdose.预防阿片类药物过量。
N Engl J Med. 2019 Jun 6;380(23):2246-2255. doi: 10.1056/NEJMra1807054.
6
Access to methadone clinics and opioid overdose deaths in Georgia: A geospatial analysis.佐治亚州美沙酮诊所的可及性与阿片类药物过量死亡情况：一项地理空间分析。
Drug Alcohol Depend. 2022 Sep 1;238:109565. doi: 10.1016/j.drugalcdep.2022.109565. Epub 2022 Jul 7.
7
Changes in methadone program practices and fatal methadone overdose rates in Connecticut during COVID-19.新冠疫情期间康涅狄格州美沙酮项目实践的变化及美沙酮过量致死率
J Subst Abuse Treat. 2021 Dec;131:108449. doi: 10.1016/j.jsat.2021.108449. Epub 2021 Apr 29.
8
Duration of use and outcomes among people with opioid use disorder initiating methadone and buprenorphine in Ontario: a population-based propensity-score matched cohort study.在安大略省，使用美沙酮和丁丙诺啡治疗阿片类药物使用障碍的患者的使用时间和结局：一项基于人群的倾向评分匹配队列研究。
Addiction. 2022 Jul;117(7):1972-1981. doi: 10.1111/add.15862. Epub 2022 Mar 21.
9
Comparing methadone policy and practice in France and the US: Implications for US policy reform.比较法国和美国的美沙酮政策和实践：对美国政策改革的启示。
Int J Drug Policy. 2024 Jul;129:104487. doi: 10.1016/j.drugpo.2024.104487. Epub 2024 Jun 14.
10
Adoption of methadone take home policy by U.S. state opioid treatment authorities during COVID-19.美国各州阿片类药物治疗机构在新冠疫情期间采用美沙酮带回家政策。
Int J Drug Policy. 2024 Feb;124:104302. doi: 10.1016/j.drugpo.2023.104302. Epub 2024 Jan 5.
引用本文的文献
1
Interrogating perceived relevance and feasibility of HIV pre-exposure prophylaxis: A novel model of PrEP acceptability among cisgender women who inject drugs.探讨艾滋病病毒暴露前预防的感知相关性和可行性：注射毒品的顺性别女性中暴露前预防可接受性的新模型。
SSM Qual Res Health. 2023 Dec;4. doi: 10.1016/j.ssmqr.2023.100337. Epub 2023 Sep 14.
2
Innovations at the intersection of homelessness and substance use during the COVID-19 pandemic: a scoping review.新冠疫情期间无家可归与药物使用交叉领域的创新：一项范围综述
Harm Reduct J. 2025 Jul 29;22(1):132. doi: 10.1186/s12954-025-01235-7.
3
Methadone-involved overdose deaths in urban and rural communities before and after the public health emergency flexibilities for methadone take-home doses.在美沙酮带回家剂量的公共卫生应急灵活性措施实施前后，城市和农村社区中与美沙酮相关的过量死亡情况。
Drug Alcohol Depend Rep. 2025 Apr 24;15:100339. doi: 10.1016/j.dadr.2025.100339. eCollection 2025 Jun.
4
Impact of guidance issued during COVID-19 to expand take-home doses of opioid agonist treatment (OAT) in Ireland: protocol for a population-based analysis of prescribing practices and patient outcomes 2018 to 2023.新冠疫情期间发布的指南对爱尔兰扩大阿片类激动剂治疗（OAT）带回家剂量的影响：2018年至2023年基于人群的处方实践和患者结局分析方案
HRB Open Res. 2025 Apr 7;8:32. doi: 10.12688/hrbopenres.14044.2. eCollection 2025.
5
Comparative effectiveness of methadone take-home dose initiation in British Columbia, Canada: protocol for a population-based retrospective cohort study using target trial guidelines.加拿大不列颠哥伦比亚省美沙酮带回家剂量起始的比较效果：一项基于目标试验指南的人群回顾性队列研究方案
BMJ Open. 2025 Mar 5;15(3):e095198. doi: 10.1136/bmjopen-2024-095198.
6
Perspectives of substance use disorder counselors on the benefits and drawbacks of medications for opioid use disorder.物质使用障碍咨询师对阿片类物质使用障碍药物治疗利弊的看法。
Addict Sci Clin Pract. 2025 Feb 4;20(1):7. doi: 10.1186/s13722-025-00537-2.
7
State Medicaid Policies Governing Access to Medications for Opioid Use Disorder (MOUD) and MOUD Treatment Use in a Large Sample of People Who Inject Drugs in 20 U.S. States.美国20个州针对注射吸毒者的大样本群体制定的关于获得阿片类物质使用障碍药物（MOUD）及MOUD治疗使用的医疗补助政策。
Subst Use Misuse. 2025;60(4):531-541. doi: 10.1080/10826084.2024.2440365. Epub 2024 Dec 31.
8
Clinician and Practice Characteristics Associated With Support of Office-based Methadone: Findings From a National Survey.与门诊美沙酮支持相关的临床医生和实践特征：一项全国性调查的结果
J Addict Med. 2025;19(2):150-156. doi: 10.1097/ADM.0000000000001388. Epub 2024 Oct 30.
9
Buprenorphine/Naloxone vs Methadone for the Treatment of Opioid Use Disorder.丁丙诺啡/纳洛酮与美沙酮治疗阿片类物质使用障碍的比较
JAMA. 2024 Dec 3;332(21):1822-1831. doi: 10.1001/jama.2024.16954.
10
Methadone Take-Home Policies and Associated Mortality: Permitting versus Non-Permitting States.美沙酮带回家政策及相关死亡率：允许与不允许的州对比
Subst Use. 2024 Aug 16;18:29768357241272379. doi: 10.1177/29768357241272379. eCollection 2024 Jan-Dec.
Zotero 插件